Mizuho Securities analyst Steven Valiquette has maintained their neutral stance on HSIC stock, giving a Hold rating on January 23.Invest with ...

Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz from ...

Health-care companies fell amid mixed earnings. Shares of Danaher, which makes tools and equipment for the biotech, life-sciences and diagnostics businesses, plunged by roughly 10% after it posted ...

Fourth-quarter per-share earnings of 80 cents top analysts' estimates of 46 cents. The Spanish bank, which generates most of its income from outside the country, expects growth this year after 2024 ...

Fourth-quarter per-share earnings of 80 cents top analysts' estimates of 46 cents. The Spanish bank, which generates most of its income from outside the country, expects growth this year after 2024 ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

East Coast Asset Management partnered with Eolas Capital to expand into the U.S. market with a new investment vehicle based ...

Petra Capital raises $270 million for fifth growth fund, Northwind Group funds $135 million Pfizer HQ conversion loan.